➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Baxter
Harvard Business School
AstraZeneca

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SARECYCLINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for sarecycline hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02320149 ↗ Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne Recruiting Warner Chilcott Phase 3 2014-12-01 To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02322866 ↗ Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne Recruiting Warner Chilcott Phase 3 2014-12-01 To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02413346 ↗ A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris Active, not recruiting Warner Chilcott Phase 3 2015-03-01 Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day dose of oral sarecycline in the long-term treatment of subjects with moderate to severe facial acne vulgaris.
NCT02651012 ↗ Study to Evaluate the Efficacy and Safety of 1.5 mg/kg/Day of Sarecycline vs Placebo in the Treatment of Acne Vulgaris Withdrawn Sadick Research Group Phase 3 2015-03-01 A Study to Evaluate the Efficacy and Safety Sarecycline in the Treatment of Acne Vulgaris.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for sarecycline hydrochloride

Condition Name

Condition Name for sarecycline hydrochloride
Intervention Trials
Acne Vulgaris 4
Acne Rosacea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for sarecycline hydrochloride
Intervention Trials
Acne Vulgaris 4
Rosacea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for sarecycline hydrochloride

Trials by Country

Trials by Country for sarecycline hydrochloride
Location Trials
United States 75
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for sarecycline hydrochloride
Location Trials
New York 4
Kentucky 4
North Carolina 3
Georgia 3
Illinois 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for sarecycline hydrochloride

Clinical Trial Phase

Clinical Trial Phase for sarecycline hydrochloride
Clinical Trial Phase Trials
Phase 4 1
Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for sarecycline hydrochloride
Clinical Trial Phase Trials
Active, not recruiting 2
Recruiting 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sarecycline hydrochloride

Sponsor Name

Sponsor Name for sarecycline hydrochloride
Sponsor Trials
Warner Chilcott 3
Derm Research, PLLC 1
Sadick Research Group 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for sarecycline hydrochloride
Sponsor Trials
Industry 3
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
Moodys
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.